🔎 Trials Near Me

Почетна › Прекумерна телесна тежина › Мисури

Клинички испитувања за Прекумерна телесна тежина во Мисури

34 студии за Прекумерна телесна тежина бараат учесници на локации во Мисури.

Градови во Мисури

Официјален текст на студијата (англиски)

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

  • Studymetrix Research /ID# 282163, City of Saint Peters
Се регрутираФаза 2
Возраст од 18 до 75 · Сите полови · Ажурирано 2.10.2026 · NCT07752979

Effects of Pistachios on Postprandial Metabolic Responses in Adults With Overweight or Obesity

  • Saint Louis University, St Louis
Се регрутира
Возраст од 18 до 35 · Сите полови · Ажурирано 2.10.2026 · NCT07853898

Two-Week Stair-Climbing Exercise Snacks and Metabolic Health in Adults With Overweight or Obesity: A Pilot Study

  • Saint Louis University, St Louis
Се регрутираДобредојдени се здрави волонтери
Возраст од 18 до 35 · Сите полови · Ажурирано 30.9.2026 · NCT07849439

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

  • StudyMetrix Research LLC, City of Saint Peters
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 28.9.2026 · NCT07720271

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

  • Amicis Centers of Clinical Research, St Louis
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 28.9.2026 · NCT07668414

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

  • Clinvest Headlands Llc, Springfield
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 28.9.2026 · NCT07794579

A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus

  • Research Site, Kansas City
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 25.9.2026 · NCT07776509

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

  • Washington University School of Medicine, St Louis
Се регрутираФаза 3
Возраст од 18 до 70 · Сите полови · Ажурирано 24.9.2026 · NCT06937099

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

  • Sundance Clinical Research, St Louis
Се регрутираФаза 3
Возраст од 6 до 17 · Сите полови · Ажурирано 24.9.2026 · NCT06672549

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

  • Washington University School of Medicine, St Louis
Се регрутираФаза 3
Возраст од 18 до 70 · Сите полови · Ажурирано 24.9.2026 · NCT06937086

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

  • Clinical Research Professionals, Chesterfield
  • Clinvest Headlands Llc, Springfield
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 22.9.2026 · NCT07282600

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

  • Clinical Research Professionals, Chesterfield
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 22.9.2026 · NCT07392190

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

  • Research Site, Kansas City
  • Research Site, Kansas City
  • Research Site, St Louis
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 22.9.2026 · NCT07784270

A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight

  • Clayton Sleep Institute - St. Louis - Tesson Ferry Road, St Louis
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 22.9.2026 · NCT07369011

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

  • StudyMetrix Research, City of Saint Peters
  • Alliance for Multispecialty Research - Kansas City, Kansas City
  • Kansas City Veterans Affairs Medical Center, Kansas City
  • и уште 1
Се регрутираФаза 3
Возраст од 45 до 99 · Сите полови · Ажурирано 22.9.2026 · NCT07037433

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

  • StudyMetrix Research, City of Saint Peters
  • Clinvest Headlands Llc, Springfield
Се регрутираФаза 2
Возраст од 18 до 75 · Сите полови · Ажурирано 22.9.2026 · NCT07589608

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

  • AURORA-1 Clinical Site, St Louis
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 16.9.2026 · NCT07743463

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

  • AURORA-2 Clinical Site, Columbia
  • AURORA-2 Clinical Site, St Louis
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 16.9.2026 · NCT07743450

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

  • Kansas City VA Medical Center, Kansas City
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 14.9.2026 · NCT07351058

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

  • Clinvest Research LLC, Springfield
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 14.9.2026 · NCT07351045

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

  • ACCOMPLISH-2 Research Site, Chesterfield
  • ACCOMPLISH-2 Research Site, City of Saint Peters
  • ACCOMPLISH-2 Research Site, Hazelwood
  • и уште 2
Се регрутираФаза 3Добредојдени се здрави волонтери
Возраст од 18 до 79 · Сите полови · Ажурирано 11.9.2026 · NCT07654374

Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight

  • StudyMetrix Research LLC, City of Saint Peters
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 9.9.2026 · NCT07770841

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

  • StudyMetrix Research, City of Saint Peters
  • Clinvest Headlands Llc, Springfield
Се регрутираФаза 2
Возраст од 18 до 75 · Сите полови · Ажурирано 8.9.2026 · NCT06143956

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

  • Alliance for Multispecialty Research - Kansas City, Kansas City
Се регрутираФаза 3
Возраст од 18 до 99 · Сите полови · Ажурирано 3.9.2026 · NCT07684235

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

  • Alliance for Multispecialty Research - Kansas City, Kansas City
Се регрутираФаза 3
Возраст од 18 до 99 · Сите полови · Ажурирано 3.9.2026 · NCT07684144

A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

  • Research Site, Jefferson City
  • Research Site, Kansas City
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 25.8.2026 · NCT07784725

AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain

  • Clinvest Research, Springfield
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 17.8.2026 · NCT07509307

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

  • ACCOMPLISH-1 Research Site, Chesterfield
  • ACCOMPLISH-1 Research Site, Hazelwood
  • ACCOMPLISH-1 Research Site, St Louis
Се регрутираФаза 3
Возраст од 18 до 79 · Сите полови · Ажурирано 10.8.2026 · NCT07654361

Advancing Biopsychosocial Care Training Initiative

  • Washington University School of Medicine, St Louis
Се регрутираДобредојдени се здрави волонтери
Возраст 5 и постари · Сите полови · Ажурирано 10.8.2026 · NCT07049861

Effects of Grape Consumption on the Immune-Gut Axis in Obesity

  • University of Missouri-Columbia, Columbia
Се регрутира
Возраст од 18 до 60 · Сите полови · Ажурирано 31.7.2026 · NCT07231484

Effect of Ketone Esters on Liver Fat Content and Metabolic Function

  • Washington University School of Medicine, St Louis
Се регрутираФаза 2Добредојдени се здрави волонтери
Возраст од 18 до 40 · Сите полови · Ажурирано 15.7.2026 · NCT07097506

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MBX 4291 in Adult Participants With Obesity

  • MBX Biosciences Investigational Site, Kansas City
Се регрутираФаза 1
Возраст од 18 до 65 · Сите полови · Ажурирано 9.6.2026 · NCT07142707

Brain Health in Youth With Normal Weight, Overweight and Obesity at Risk for Type 2 Diabetes (T2D)

  • Washington University School of Medicine, St Louis
Се регрутираНабљудувачка студијаДобредојдени се здрави волонтери
Возраст од 12 до 17 · Сите полови · Ажурирано 18.12.2025 · NCT05277558

Social Determinants and a Diabetes Prevention Program Tailored for African Americans

  • University Health, Kansas City
  • University of Missouri-Kansas City, Kansas City
Се регрутираФаза 2Добредојдени се здрави волонтери
Возраст 18 и постари · Сите полови · Ажурирано 25.5.2025 · NCT05301413

Од ClinicalTrials.gov, податоци преземени 5.10.2026. Секоја студија ги поставува своите услови за вклучување; тимот на студијата одлучува кој може да учествува.